Skip to main content

Smith, Moore & Co.

SEC CIK
0000200724
Latest filing
Aug 12, 2026

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by Smith, Moore & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings

Shares (Q4 2024)
0
Sold out in Q4 2024
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q3 2024
Holdings of VRTX by Smith, Moore & Co., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20240$00.0%−455−100.0%Sold outHolders
Q3 2024455$211.6K<0.1%+455NewHolders